LINC02599

Across TCGA pan-cancer cohorts, LINC02599 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC02599 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02599 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02599 expression acts as an unfavorable survival marker, although some lineages such as BRCA and ESCA show a favorable association.

BLCA, LGG, and OV are the cancer types where LINC02599 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	II,III,IV	0.450	0.565	.003	64	view →
LGG	OS	Median	All	0.722	0.862	<.001	47	view →
OV	OS	Median	All	0.820	0.860	.017	32	view →
BRCA	OS	Quartile	III,IV	0.925	0.756	.002	29	view →
ACC	DFS	Tertile	II,III,IV	0.519	0.771	.006	26	view →
STAD	OS	Tertile	II,III,IV	0.238	0.565	.019	25	view →
MESO	OS	Tertile	All	0.217	0.681	.006	23	view →
DLBC	DFS	Median	All	0.339	1.000	<.001	22	view →
LUAD	DFS	Median	IV	0.332	0.641	.011	20	view →
COAD	DFS	Tertile	IV	0.222	0.600	.006	19	view →
ESCA	OS	Tertile	IV	0.738	0.238	.024	18	view →
UVM	OS	Tertile	III,IV	0.452	0.929	.017	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC02599–BLCA (DFS)

Open the BLCA breakdown →